Page URL: https://www.bionews.org.uk/page_92334

Multiple Sclerosis stem cell therapy trialled

10 May 2010
Appeared in BioNews 557

A clinical trial investigating the treatment of patients with multiple sclerosis (MS) using bone marrow stem cells has produced encouraging results, researchers at Bristol University have reported.

In the phase I clinical trial, six MS patients were injected with stem cells harvested from their own bone marrow. The main aim of the study was to determine whether this procedure was safe and free from side effects. The researchers also regularly tested the patients for disease progression.

The study, carried out at Frenchay Hospital, found no serious side effects associated with the procedure. It also found that the MS was stable in five out of the six patients receiving bone marrow stem cells, and did not deteriorate over the twelve month period.

Dr Claire Rice, Research Fellow at the University of Bristol, said: 'The results are very encouraging. We would have expected these pathways to get worse but they have actually got better. It is exciting because the treatment is relatively pain free and patients do not need to stay overnight in hospital'.

Liz Allison, one of the volunteers being studied, said: 'My long-term hope is that stem cell research will be a cure for MS and will be available for everyone who is afflicted with this disease. It has the added benefit of being a relatively pain-free procedure and having no side effects'.

Professor Scolding added: 'Research into the underlying mechanisms is ongoing and vital, in order to build on these results. We believe that stem cells mobilised from the marrow to the blood are responsible, and that they help improve disease in several ways, including neuroprotection and immune modulation'.

These results are preliminary, and the researchers are planning a larger trial of the treatment. Professor Neil Scolding, Professor of Clinical Neuroscience at North Bristol NHS Trust, said: 'A larger study is required to assess the effectiveness of bone marrow cellular therapy in treating MS. We are hopeful that recruitment to this phase 2/3 study may begin towards the end of this year'.

The advantage of this technique is that it uses patients' own adult bone marrow stem cells, which reduces the risk of rejection and carries no ethical implications.

The study was published in the Journal of Clinical Pharmacology and Therapeutics.

SOURCES & REFERENCES
Controversial stem cell trial 'has helped stabilise MS'
Daily Mail |  6 May 2010
Frenchay Hospital trials offer MS stem cell hopes
BBC News |  5 May 2010
MS patients treated with stem cells
The Press Association |  6 May 2010
MS stem cell therapy trialled
NHS Choices |  6 May 2010
Stem cells raise hope for treatment for multiple sclerosis patients
The Telegraph |  5 May 2010
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
8 August 2011 - by Dr Rebecca Hill 
More than £600,000 has been donated to the Frenchay Hospital in Bristol for research into the use of stem cells as a treatment for multiple sclerosis (MS)....
1 August 2011 - by Dr Caroline Hirst 
UK scientists are launching a global clinical trial to test the potential and safety of stem cells to treat multiple sclerosis (MS)...
13 December 2010 - by Chris Chatterton 
Preliminary findings from a new research study have helped give scientists a new insight into how the body naturally repairs myelin, the substance that insulates nerve cells in the brain...
17 May 2010 - by Kyrillos Georgiadis 
US Scientists have produced mouse inner ear hair cells using stem cells, paving the way for a cure for deafness and other related balance disorders...
1 February 2010 - by Ben Jones 
The Multiple Sclerosis (MS) Society and the UK Stem Cell Foundation (UKSCF) have announced a funding competition for a million pounds of seed capital to help research into multiple sclerosis in the UK. The money, which has been contributed from the budgets of both organistations is to be employed to 'pump-prime and speed up stem cell research' in relation to the condition in the hope of bringing novel stem cell technologies to the clinic sooner than would otherwise be possible....
27 April 2009 - by Alison Cranage 
A report published in the Journal of Translational Medicine shows that stem cells taken from patients' adipose (fat) tissue may be able help relieve the symptoms of multiple sclerosis (MS). In the preliminary study by researchers from Medistem Inc. and the Division of Neurosurgery, University of California...
1 February 2009 - by Dr Rebecca Robey 
A promising new stem cell therapy has reversed the effects of multiple sclerosis (MS) for the first time. In a small clinical trial published in the journal Lancet Neurology, researchers from the Northwestern Freinberg School of Medicine, Chicago, US, treated MS sufferers with their own stem cells...
9 June 2008 - by Alison Cranage 
Scientists at the University of Rochester, New York, have spectacularly improved the condition of mice with a normally fatal neurological disease, by injecting them with human stem cells. The research was published in the journal Cell: Stem Cell last week, and has positive implications for the treatment...
1 October 2007 - by Katy Sinclair 
By Katy Sinclair: Tests taking place at the Frenchay Hospital near Bristol, UK, have raised hopes that stem cell injections could reverse the physical decline experienced by multiple sclerosis (MS) patients. The trial, led by Neil Scolding, professor of clinical neurosciences for North Bristol NHS Trust, involves injecting patients with...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.